EU authorizes Eisai-Biogen's drug for early Alzheimer's treatmentE
Continue reading...
EU authorizes Eisai-Biogen’s drug for early Alzheimer’s treatment
EU authorizes Eisai-Biogen's drug for early Alzheimer's treatment
The European Commission on Tuesday authorized the use of Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab drug...